# OnCo record colorado-cancer-center (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/colorado-cancer-center/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "colorado-cancer-center" ;
  schema:name "University of Colorado Cancer Center"@en ;
  schema:alternateName "CU Cancer Center"@en ;
  schema:description "The University of Colorado Cancer Center serves the Rocky Mountain states; its thoracic oncology group defined how ALK, ROS1 and NTRK fusion-driven lung cancers behave and helped bring crizotinib, entrectinib and larotrectinib to patients, and it holds a lung cancer SPORE grant."@en ;
  schema:url <https://onco.cc/institutions/colorado-cancer-center/>, <https://medschool.cuanschutz.edu/colorado-cancer-center> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://medschool.cuanschutz.edu/colorado-cancer-center>, <https://medschool.cuanschutz.edu/colorado-cancer-center/clinical-trials> ;
  schema:addressCountry "US" ;
  schema:addressLocality "Aurora, CO" ;
  schema:latitude "39.745"^^xsd:decimal ;
  schema:longitude "-104.838"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/alk/>, <https://onco.cc/targets/ros1/>, <https://onco.cc/targets/ntrk/> ;
  onco:drugs <https://onco.cc/drugs/crizotinib/>, <https://onco.cc/drugs/entrectinib/>, <https://onco.cc/drugs/larotrectinib/>, <https://onco.cc/drugs/lorlatinib/> ;
  onco:terms <https://onco.cc/terms/gene-fusion/>, <https://onco.cc/terms/oncogene-addiction/> ;
  onco:people <https://onco.cc/people/richard-schulick/>, <https://onco.cc/people/ross-camidge/>, <https://onco.cc/people/sapna-patel/> .